[Regulation of fat metabolism to reduce coronary risk. Product workshop "Clinical results with Normalip 250 N." Copenhagen, 3 June 1989. Abstracts].
D003327:Coronary Disease / Q000517:prevention & control*; D011345:Fenofibrate / Q000494:pharmacology*; D006801:Humans; D050356:Lipid Metabolism; D011422:Propionates / Q000494:pharmacology*
D011422:Propionates; D011345:Fenofibrate
Regulation des Fettstoffwechsels senkt Koronarrisiko. Produktworkshop "Klinische Erfahrungen mit Normalip 250 N", Kopenhagen, am 3. Juni 1989.